We and others have shown increased pattern recognition receptors, TLR2 and TLR4, in diabetes and have also shown that knockout of TLR2 and/or TLR4 in a mouse model can result in decreased microvascular complications using the streptozotocin- (STZ-) induced diabetes model [4–6]. Here, TLR2 is linked to diabetes mellitus.